Trial Details

Not Recruiting
Basic Information
Clinical ID c5508
Identifier ACTRN12611000363987
Trial Title The Triple A (Adjunctive Allopurinol and Azathioprine) Study: Use of Ajunctive Allopurinol in Azathioprine/6-Mercaptopurine Non-responders to Optimize 6-Thioguanine Nucleotide Production and Improve Clinical Outcomes in Patients with Inflammatory Bowel Di
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease (IBD); Inflammatory Bowel Disease (IBD);Oral and Gastrointestinal - Inflammatory bowel disease;Inflammatory and Immune System - Other inflammatory or immune system disorders
Interventions Eligible IBD patients will be randomly allocated to receive either 100mg or 50mg of allopurinol orally in 1:1 using computer generated list. Patients will continue to take their usual azathioprine or 6-mercaptopurine at reduced doses as determined by the
Participant Information
Sponsor The Alfred Hospital
City NULL
Country/Region Australia;New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type Interventional
Phase PHASE3|PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL